Aadi Bioscience Inc (AADI) FinancialsAADIFinancialAadi Bioscience Inc

Evaluating the bottom line, Aadi Bioscience Inc maintains a gross margin of 89.09%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -261.76%, while the net margin is -252.42%. These profitability ratios, combined with a Return on Equity (ROE) of -80.79%, provide a clear picture of how effectively AADI converts its operational activities into shareholder value.

In the context of the broader market, AADI competes directly with industry leaders such as PRLD and IPSC. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, AADI's gross margin of 89.09% stands against PRLD's 100.00% and IPSC's N/A. Such benchmarking helps identify whether Aadi Bioscience Inc is trading at a premium or discount relative to its financial performance.